Regulatory Resources

Clinical guidelines, MDCG guidance, FDA guidance, standards, and compliance tools

Home/Resources
All Categories
American Guidelines 221 Annex XVI Products 3 Borderline and Classification 5 Brazil (ANVISA) 1 Cardiology & Vascular 19 Cardiology & Vascular 47 China (NMPA) 1 Class I Devices 1 Clinical Investigation and Evaluation 17 Dermatology & Venereology 12 Dermatology & Venereology 7 Endocrinology, Diabetes & Metabolism 19 Endocrinology, Diabetes & Metabolism 20 EU 3 EU Regulation 2 EUDAMED 2 European Guidelines 510 Eye, ENT & Neurosensory 5 Eye, ENT & Neurosensory 7 FDA Guidance 106 Gastroenterology & Hepatology 40 Gastroenterology & Hepatology 47 Imaging & Radiology 6 Imaging & Radiology 5 IMDRF Documents 115 India (CDSCO) 1 Infectious Diseases & Microbiology 31 Infectious Diseases & Microbiology 13 Internal Medicine & Emergency 14 Internal Medicine & Emergency 4 IVDR 2 Japan (PMDA) 1 MDCG Guidance 54 MDR 8 Medical Guidelines & Recommendations 731 Medical Technology & Engineering 0 Medical Technology & Engineering 0 NB White Papers 15 Neurology & Neurosurgery 56 Neurology & Neurosurgery 12 New Technologies 7 Notified Bodies 4 Oncology & Haematology 74 Oncology & Haematology 33 Other / Transition 5 Paediatrics 16 Paediatrics 6 Post-Market Surveillance and Vigilance 5 Public Health & Primary Care 39 Public Health & Primary Care 8 Regulations 17 Rehabilitation & Geriatrics 4 Rehabilitation & Geriatrics 15 Respiratory & Intensive Care 29 Respiratory & Intensive Care 8 Rheumatology & Immunology 29 Rheumatology & Immunology 11 South Korea (MFDS) 1 Standards 51 Surgery & Orthopaedics 5 Surgery & Orthopaedics 30 Team NB Documents 50 UDI 4 UK (MHRA) 1 Umbrella & Cross-Cutting 8 Umbrella & Cross-Cutting 0 US (FDA) 8 Women's Health & Obstetrics 33 Women's Health & Obstetrics 12
1,129 resources

Benefit-Risk Factors to Consider When Determining Substantial Equivalence in 510(k) Submissions

FDA Guidance 2018-09-01 FDA Guidance

Final FDA guidance on 510(k). Published 2018 by CDRH/CBER.

Download PDF

Manufacturing Site Change Supplements: Content and Submission

FDA Guidance 2018-12-01 FDA Guidance

Final FDA guidance on manufacturing. Published 2018 by CDRH/CBER.

Download PDF

User Fees and Refunds for Premarket Approval Applications and Device BLAs

FDA Guidance 2018-12-01 FDA Guidance

Final FDA guidance on user fees. Published 2018 by CDRH/CBER.

Download PDF

The Least Burdensome Provisions: Concept and Principles

FDA Guidance 2019-02-01 FDA Guidance

Final FDA guidance on submission process. Published 2019 by CDRH/CBER.

Download PDF

Unique Device Identification: Convenience Kits

FDA Guidance 2019-04-01 FDA Guidance

Final FDA guidance on udi. Published 2019 by CDRH/CBER.

Download PDF

Factors to Consider When Making Benefit-Risk Determinations in Medical Device Premarket Approval and De Novo

FDA Guidance 2019-08-01 FDA Guidance

Final FDA guidance on benefit-risk. Published 2019 by CDRH/CBER.

Download PDF

Humanitarian Device Exemption (HDE) Program

FDA Guidance 2019-09-01 FDA Guidance

Final FDA guidance on hde. Published 2019 by CDRH/CBER.

Download PDF

The Special 510(k) Program

FDA Guidance 2019-09-01 FDA Guidance

Final FDA guidance on 510(k). Published 2019 by CDRH/CBER.

Download PDF

The Abbreviated 510(k) Program

FDA Guidance 2019-09-01 FDA Guidance

Final FDA guidance on 510(k). Published 2019 by CDRH/CBER.

Download PDF

Refuse to Accept Policy for 510(k)s

FDA Guidance 2019-09-01 FDA Guidance

Final FDA guidance on 510(k). Published 2019 by CDRH/CBER.

Download PDF
Loading more resources…
Scroll to Top